Quarterly 13F snapshot: US-listed longs only, no performance figures — 13F data cannot support them.
Reported portfolio value by quarter (2 quarters reported)
$113K in Q2 2013 → $49K now. Hover for any quarter.
As reported for the quarter ended September 30, 2013. Activity is the change in share count since the prior quarter's filing.
| Holding | % of portfolio | Activity | Shares | Value |
|---|---|---|---|---|
| K Kior Inc | 100.0% | New | 17,487 | $49K |
What changed each quarter, from the filings' own share counts. Largest moves first; most recent 1 quarters.
quarter ended September 30, 2013 · filed October 23, 2013
| Company | Action | Shares changed | Value of change | % of portfolio |
|---|---|---|---|---|
| PP Pacira Pharmaceuticals Inc | Exited | −3,903 | −$113K | — |
| K Kior Inc | New | +17,487 | +$49K | 100.0% |
Loading...
